Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lafyatis

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|June 3, 2018
Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic SclerosisGiuseppina Stifano, Thierry Sornasse, Lisa M Rice, et al.
Arthritis Research & Therapy|July 3, 2014
Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosisGiuseppina Stifano, Alsya J Affandi, Allison L Mathes, et al.
Journal of Scleroderma and Related Disorders|December 1, 2018
Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung diseaseMatthew Moll, Romy B Christmann, Yuqing Zhang, et al.
Arthritis and Rheumatism|March 23, 2011
Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertensionRomy B Christmann, Everett Hayes, Sarah Pendergrass, et al.
PNAS Nexus|September 26, 2022
SECANT: a biology-guided semi-supervised method for clustering, classification, and annotation of single-cell multi-omicsXinjun Wang, Zhongli Xu, Haoran Hu, et al.
JCI Insight|April 8, 2025
Unique and shared transcriptomic signatures underlying localized scleroderma pathogenesis identified using interpretable machine learningAaron Bi Rosen, Anwesha Sanyal, Theresa Hutchins, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosisMinghua Wu, Mesias Pedroza, Robert Lafyatis, et al.
Annals of the Rheumatic Diseases|June 2, 2018
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosisChristopher P Denton, Voon H Ong, Shiwen Xu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2016
An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma FibrosisFlavia V Castelino, Gretchen Bain, Veronica A Pace, et al.
The Journal of Investigative Dermatology|March 11, 2014
High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosisSarah T Arron, Michelle T Dimon, Zhenghui Li, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Arthritis & Rheumatology (Hoboken, N.J.)|June 3, 2018
Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic SclerosisGiuseppina Stifano, Thierry Sornasse, Lisa M Rice, et al.
Arthritis Research & Therapy|July 3, 2014
Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosisGiuseppina Stifano, Alsya J Affandi, Allison L Mathes, et al.
Journal of Scleroderma and Related Disorders|December 1, 2018
Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung diseaseMatthew Moll, Romy B Christmann, Yuqing Zhang, et al.
Arthritis and Rheumatism|March 23, 2011
Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertensionRomy B Christmann, Everett Hayes, Sarah Pendergrass, et al.
PNAS Nexus|September 26, 2022
SECANT: a biology-guided semi-supervised method for clustering, classification, and annotation of single-cell multi-omicsXinjun Wang, Zhongli Xu, Haoran Hu, et al.
JCI Insight|April 8, 2025
Unique and shared transcriptomic signatures underlying localized scleroderma pathogenesis identified using interpretable machine learningAaron Bi Rosen, Anwesha Sanyal, Theresa Hutchins, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosisMinghua Wu, Mesias Pedroza, Robert Lafyatis, et al.
Annals of the Rheumatic Diseases|June 2, 2018
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosisChristopher P Denton, Voon H Ong, Shiwen Xu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2016
An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma FibrosisFlavia V Castelino, Gretchen Bain, Veronica A Pace, et al.
The Journal of Investigative Dermatology|March 11, 2014
High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosisSarah T Arron, Michelle T Dimon, Zhenghui Li, et al.
Pageof 20